Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy Discovery, Development, and Manufacturing Kytopen launches early access program for strategic placements of the Flowfect DiscoverTM platform at top CDMOs and Translational Academic Medical Centers for rapid delivery of genome engineering materials to living medicines. This program accelerates drug discovery, streamlines optimization, and eliminates barriers […]
Company will use its deep technology expertise to deliver actionable phenotypic data for tissue profiling studies MENLO PARK, Calif. — Ionpath, a pioneer in high-definition spatial proteomics, today announced a rebalancing of the company’s focus toward its Spatial Proteomics Services. The company will suspend sales of its multiplexed ion beam imaging (MIBI™) technology as a […]
GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 SAN DIEGO –TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the expansion of its mRNA manufacturing capabilities to serve late-phase drug developers. TriLink’s construction of the new 32,000-square-foot, cGMP-grade […]
In an effort to continue providing the highest quality of laboratory services and state-of-the art technologies to our customers, FlowMetric accepted the opportunity to collaborate directly with Cytek™Biosciences in providing feedback on the pre-designed panels associated with their next generation of flow cytometric instrumentation. The Cytek Aurora leverages full spectrum technology to provide unprecedented flexibility and stability, enabling the use of […]
Traditional DNA synthesis has long been plagued by slow, low-quality results, creating a bottleneck for researchers and impeding progress in both academic and industrial fields; in response, GenScript has launched a groundbreaking solution with the first and only commercial miniature semiconductor platform that utilizes integrated circuits to deliver high-throughput DNA synthesis. OAKLAND, Calif. — (#SynBioBeta2023, […]
The cutting-edge software integration enables researchers to design oligo assembly reactions, automate the reaction setup, order the needed DNA, and integrate with lab automation, all within a single platform PORTOLA VALLEY, Calif. — TeselaGen Biotechnology Inc., pioneer in AI-enabled Operating Systems for Biotechnology R&D and Manufacturing announces a strategic partnership with NinthBio LLC, the visionary Smart DNA Assembly […]
Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines. Transformation of Grade II-listed Victorian waterworks on the River Thames in Hampton, London. Supplying many of the top biopharmaceutical companies in the world to dramatically enhance their ability to develop genetic medicines. Expansion follows recent acceptance of a Drug […]
SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the Institute of Oncology Ljubljana (IOL), a comprehensive public institution for detection, treatment and research of cancer, based […]
New branding reflects customer-centric approach and showcases pioneering, single cell analysis technology Rebrand follows a period of significant growth for the Company, including key leadership team appointments, state-of-the-art facility expansion, and new scientific partnerships Cambridge, UK: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of […]
Researchers can now order their mutation of choice in bit.bio’s opti-oxTM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated into drug discovery workflows. The disease model cells will support scientists in the generation of data in a human context with improved translatability in early stage drug discovery. Aligns with the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
